Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 53 for “"D, L - lactic"”.

  1. Delivery of oseltamivir phosphate and gemcibatine from implantable poly (D,L-lactic-co-glycolic acid) cylinders for the treatment of pancreatic cancer

    … the study was to develop implantable poly (D,L-lactic-co-glycolic acid) (PLGA) cylinders capable of releasing oseltamivir phosphate (OP) and gemcitabine (GEM) over 30 days and to establish proof of principle for the sustained delivery of OP and GEM for the treatment of pancreatic cancer. …

    queens Repository record for Delivery of oseltamivir phosphate and gemcibatine from implantable poly (D,L-lactic-co-glycolic acid) cylinders for the treatment of pancreatic cancer (opens in a new tab)

  2. COAXIAL DOUBLE-WALLED MICROSPHERES FOR DRUG AND GENE DELIVERY APPLICATIONS

    … microspheres consisting of a poly(D,L-lactic-co-glycolic acid) (PLGA) core surrounded by a poly(D,L-lactic acid) (PDLLA) or poly(L-lactic acid) (PLLA) shell layer. The work can be summarized in terms of three research goals. The first goal is to bridge the experimental work on the …

    nus Repository record for COAXIAL DOUBLE-WALLED MICROSPHERES FOR DRUG AND GENE DELIVERY APPLICATIONS (opens in a new tab) Download file for COAXIAL DOUBLE-WALLED MICROSPHERES FOR DRUG AND GENE DELIVERY APPLICATIONS (opens in a new tab)

  3. 3D scaffolds for tissue engineering produced by microfabrication technology

    … in-house built microfabrication system. Poly(D,L-lactic acid) (PDLA), poly(D,L-lactic-co-glycolic acid) (PLGA) and chitosan scaffolds presenting homogeneously distributed 100 Âμm size pores were fabricated. Fabrication consisted in a layer by layer deposition of filaments of PDLA and PLGA …

    trento Repository record for 3D scaffolds for tissue engineering produced by microfabrication technology (opens in a new tab)

  4. Dynamics of glass forming materials

    … and rheological methods were used on D,L-lactic acid to investigate the speculation that this lactic acid should have a very extreme fragility. Results show that the dynamic fragility of D,L-lactic acid and D-lactic acid are not in the range for an extreme fragile material.

    ttu Repository record for Dynamics of glass forming materials (opens in a new tab)

  5. Improvement Of Biodegradable Biomaterials For Use In Orthopedic Fixation Devices

    … to match the growth of new bone. Poly-(D, L)-lactic-co-glycolic acid (PDLG) incorporated with hydroxylated nanodiamonds has not only been proven to start out stronger, but then also helps the polymer degrade faster when compared to the pure polymer in vivo and prevents effusion of the polymer …

    temple Repository record for Improvement Of Biodegradable Biomaterials For Use In Orthopedic Fixation Devices (opens in a new tab)

  6. Coaxial double-walled microspheres for drug and gene delivery applications

    … microspheres consisting of a poly(D,L-lactic-co-glycolic acid) (PLGA) core surrounded by a poly(D,L-lactic acid) (PDLLA) or poly(L-lactic acid) (PLLA) shell layer. The first study involves bridging the experimental work on the fabrication of double-walled microspheres from CEHDA and the …

    uiuc Repository record for Coaxial double-walled microspheres for drug and gene delivery applications (opens in a new tab)

  7. Matrix Metalloproteinase 9 (MMP-9) and Biodegradable Polymers in the Engineering of a Vascular Construct

    … scaffolds using a fast degrading poly D, L-lactic-glycolic acid co-polymer (PLGA) and a slow degrading poly e-caprolactone (PCL) indicated that fast degradation negatively affects cell viability and migration into the scaffold in vitro and in vivo, which is likely due to the fast polymer …

    gatech Repository record for Matrix Metalloproteinase 9 (MMP-9) and Biodegradable Polymers in the Engineering of a Vascular Construct (opens in a new tab)

  8. Nanoparticle-based drug delivery systems for neural interfaces - a novel approach for improved biocompatibility.

    … encapsulated into biodegradable poly (D,L-lactic-co-glycolic acid) nanoparticles and thereby also protecting the drug from degradation. The nanoparticle construct resulted in a sustained release of Minocycline over 30 days. This constitutes a substantial increase in release time compared to …

    lund Repository record for Nanoparticle-based drug delivery systems for neural interfaces - a novel approach for improved biocompatibility. (opens in a new tab) Download PDF for Nanoparticle-based drug delivery systems for neural interfaces - a novel approach for improved biocompatibility. (opens in a new tab)

  9. The Efficacy of Overlapping Method Using Absorbable Copolymer in Reconstruction of Infero-medial Orbital Wall Fractures with Bony Strut Loss

    … method using Resorb X® plates (poly(D,L)-Lactic acid). METHODS: To repair infero-medial orbital wall fractures with loss of bony strut, we bent the medial aspect of plate for floor fracture according to the anatomical structure and then we inserted the floor implant as which was supported …

    ajou Repository record for The Efficacy of Overlapping Method Using Absorbable Copolymer in Reconstruction of Infero-medial Orbital Wall Fractures with Bony Strut Loss (opens in a new tab) Embargoed until 9999-12-31

  10. Novel Antipsychotic Drug Carriers: The Development of Nanoparticle and Microgel Drug Carriers for Antipsychotic Delivery in the Treatment of Schizophrenia

    … (PAOPA) and poly(ethylene glycol)–block-poly(D,L-lactic-co-glycolic acid) (PEG-PLGA) nanoparticles loaded with haloperidol were prepared with narrow size distributions and sizes < 135 nm. The microgels and nanoparticles exhibited high <em>Solanum tuberosum </em>lectin (STL) conjugation …

    mcmaster Repository record for Novel Antipsychotic Drug Carriers: The Development of Nanoparticle and Microgel Drug Carriers for Antipsychotic Delivery in the Treatment of Schizophrenia (opens in a new tab)

  11. Evaluation of Nanoparticle Formulation for Novel Synthetic Immune Stimulating Agents

    … was to investigate the efficacy of poly (D,L lactic-coglycolic acid) nanoparticles (PLGA-NPs) as a delivery system to deliver a single immunostimulatory molecule (adjuvant) or co-delivering different adjuvants in the elicitation of immune responses. The PLGA biodegradable nanoparticles …

    sask Repository record for Evaluation of Nanoparticle Formulation for Novel Synthetic Immune Stimulating Agents (opens in a new tab)

  12. Development of biocompatible polymers for ocular applications

    … Blends of the biodegradable polymers, poly(L-lactic acid) (PLLA) and poly(D,L-lactic-co-glycolic acid) (PLGA) have been formulated into microspheres. The influence of changing processing parameters on the size and morphology of the microspheres has been studied. A human retinal pigment …

    soton Download PDF for Development of biocompatible polymers for ocular applications (opens in a new tab)

  13. Inverse opal scaffolds and photoacoustic microscopy for regenerative medicine

    … of inverse opal scaffolds based on poly(D,L-lactic-co-glycolic acid) (PLGA), a biodegradable material approved by the U.S. Food and Drug Administration (FDA). The advantages of the PLGA inverse opal scaffolds are also demonstrated by comparing with their counterparts with spherical but …

    gatech Repository record for Inverse opal scaffolds and photoacoustic microscopy for regenerative medicine (opens in a new tab)

  14. Encapsulation and Controlled Release of Benzalkonium Chloride - Production of Antimicrobial Cellulose Nonwoven Fabrics for Wound Treatment

    … Based on microscopic imagery does poly(D,L-lactic-co-glycolic acid) (PLGA) formulate microspheres of desired size, morphology and encapsulation efficiency. By adding NaCl to the continuous phase, encapsulation efficiency of BAC was increased along with an increased microsphere size, however …

    chalmers Repository record for Encapsulation and Controlled Release of Benzalkonium Chloride - Production of Antimicrobial Cellulose Nonwoven Fabrics for Wound Treatment (opens in a new tab)

  15. Design of polymer systems and surface-active agents for the improvement of cell attachment for treatment of ocular diseases

    … into the biodegradable polymers poly(L-lactic acid) (PLLA) and poly(D,L-lactic-co-glycolic acid) (PLGA) as a possible drug delivery system with highly uniform and reproducible microspheres was developed. Under optimised parameters Bevacizumab-encapsulated PLLA:PLGA microspheres were …

    soton Download PDF for Design of polymer systems and surface-active agents for the improvement of cell attachment for treatment of ocular diseases (opens in a new tab)

  16. Induction of Immunity against Marek's Disease using Toll-Like Receptor Ligands

    … constituents. TLR-Ls can be used as prophylactic agents or as adjuvants to enhance immunity against infectious diseases. In this regard, TLR-Ls can be encapsulated in Poly(D, L-lactic-co-glycolic)acid to further enhance host responses by controlled release of TLR-Ls for an extended period. …

    guelph Repository record for Induction of Immunity against Marek's Disease using Toll-Like Receptor Ligands (opens in a new tab)

  17. Human in-vitro microphysiological systems integrating polymeric nanofilms and high-resolution 3D printing

    … Within this thesis, a 200-nm porous Poly(D,L-lactic acid) (PDLLA) nanofilm is proposed as an alternative to commercially available membranes for recapitulating the biomechanical properties, porosity and thickness of the BM in an endothelialbarrier- on-chip. PDLLA nanofilms demonstrate enhanced …

    whiterose Download PDF for Human in-vitro microphysiological systems integrating polymeric nanofilms and high-resolution 3D printing (opens in a new tab)

  18. ENGINEERING LYMPH-NODE TARGETING NANOPARTICLE PLATFORMS TO ENHANCE DELIVERY OF SUBUNIT VACCINES

    … (FNP) process to generate uniform poly(D,L-lactic-co-glycolic acid)-block-poly(ethylene glycol) (PLGA-b-PEG) NPs of various sizes to study LN drainage and retention in mice. We applied these findings to deliver a model antigen ovalbumin (OVA) and adjuvant CpG1018 in comparison with …

    jhu Repository record for ENGINEERING LYMPH-NODE TARGETING NANOPARTICLE PLATFORMS TO ENHANCE DELIVERY OF SUBUNIT VACCINES (opens in a new tab) Embargoed until 2027-08-01

  19. Micro/Nano-Structured implants for controlled Drug/protein delivery in chemo/anti-angiogenic therapy of malignant glioma

    … tissue was encapsulated in two types of poly(D,L-lactic-co-glycolic) acid (PLGA) based implants. First, paclitaxel-loaded PLGA was micro/nano-structured into fibers diameters ranging from micron to nanometer using electrospinning technique. Second, paclitaxel-loaded PLGA microspheres were …

    nus Repository record for Micro/Nano-Structured implants for controlled Drug/protein delivery in chemo/anti-angiogenic therapy of malignant glioma (opens in a new tab) Download file for Micro/Nano-Structured implants for controlled Drug/protein delivery in chemo/anti-angiogenic therapy of malignant glioma (opens in a new tab)

Page 1 of 3